Skip to main content

Yvonne Mowery, MD, PhD, DABR

  • Associate Professor, University of Pittsburgh Department of Radiation Oncology
  • Radiation Oncologist, UPMC Hillman Cancer Center

Yvonne Mowery, MD, PhD, DABR, is a radiation oncologist with specialized expertise in SBRT, SRS, and reirradiation, and clinical interests in head/neck cancer and skin cancer. Her research interests include immunotherapy/radiation therapy combinations, radiosensitizers, imaging biomarkers, and mouse models of cancer.

    Education & Training

  • BS: Biology, University of Virginia, 2004
  • MD & PhD: Pathology, Duke University, Medical Scientist Training Program, 2012
  • Internship: Internal Medicine, Duke University, 2013
  • Residency: Radiation Oncology, Duke University, 2013–2017 (Co-chief Resident, 2016 & 2017)
Awards
Radiation Research Society Early Career Investigator (ECI) Travel Award, 2024
Head and Neck SPORE Career Enhancement Program Award, 2024
Hillman Early-Career Fellow for Innovative Cancer Research, 2023
Radiation Research Society Early Career Investigator (ECI) Travel Award, 2022
American Society for Clinical Investigation (ASCI) Council Young Physician-Scientist Award, 2021
Sigma Xi, The Scientific Research Honor Society, 2020
K08 Mentored Clinical Scientist Research Career Development Award, National Institute of Dental and Craniofacial Research, 2020
Damon Runyon Clinical Investigator Award, Damon Runyon Cancer Research Foundation, 2020
Representative Publications

PubMed® Link: Yvonne Mowery, MD, PhD, DABR

 

Research Grants

Damon Runyon Clinical Investigator Award, Evaluating and Targeting Pathways of Treatment Resistance in Head and Neck Squamous Cell Carcinoma, Damon Runyon Cancer Research Foundation, 2020-2025 (PI)

K08 Clinical Investigator Award, Employing Novel Primary Mouse Models of Head and Neck Cancer to Overcome Chemoradiation Resistance, NIH/NIDCR, 2000-2025 (PI)

EveryCat Grant, Use of the DNA damage response inhibitor BAY 1895344 as a component of care in feline oral squamous cell carcinoma, EveryCat Health Foundation, 2023-2024 (Co-PI)

R21, The impact of TRPV1 nociceptors on radiotherapy pain and mucositis in head and neck squamous cell carcinoma, 2024-2026 (Co-PI)

R01, Radioprotective effect of p53 against oral mucositis, NIH/NIDCR, 2023-2028 (Co-I/Subcontract PI)

R01, Computational tumor phenotyping to interrogate treatment resistance and immune dysregulation in head and neck cancer, NIH/NCI, 2024-2029 (Co-I/Subcontract PI)